Russell Investments Group Portfolio holdings
AUM
$78.5B
1-Year Return
23.79%
This Quarter Return
+12.88%
1 Year Return
+23.79%
3 Year Return
+95.55%
5 Year Return
+186.04%
10 Year Return
–
AUM
$56.2B
AUM Growth
+$5.69B
(+11%)
Cap. Flow
-$230M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
19.08%
Holding
3,710
New
183
Increased
1,286
Reduced
1,419
Closed
493
Top Buys
| 1 |
Apple
AAPL
|
+$96.4M |
| 2 |
Sun Communities
SUI
|
+$76.3M |
| 3 |
Amazon
AMZN
|
+$74.3M |
| 4 |
Humana
HUM
|
+$57.5M |
| 5 |
American Tower
AMT
|
+$57M |
Top Sells
| 1 |
Prologis
PLD
|
+$56M |
| 2 |
Microsoft
MSFT
|
+$54.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$49.2M |
| 4 |
Equity Lifestyle Properties
ELS
|
+$43.4M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$42.2M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Financials | 13% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Synchronoss Technologies
SNCR
$62.8M
| $15.9K | ﹤0.01% |
2,555
-1
| -0% | -$6 |
|
2677
Piper Sandler
PIPR
$5.95B
| $15.7K | ﹤0.01% |
90
-9,408
| -99% | -$1.65M |
|
|
MRTX
2678
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.6K | ﹤0.01% |
266
-5,329
| -95% | -$313K |
|
2679
SPDR S&P Dividend ETF
SDY
$20.3B
| $15.6K | ﹤0.01% |
125
-98
| -44% | -$12.2K |
|
2680
Lemonade
LMND
$3.63B
| $15.6K | ﹤0.01% |
965
-1,205
| -56% | -$19.4K |
|
2681
Eagle Bancorp
EGBN
$596M
| $15.5K | ﹤0.01% |
515
+152
| +42% | +$4.58K |
|
|
UNIT
2682
Uniti Group
UNIT
$1.69B
| $15.4K | ﹤0.01% |
2,668
-13,928
| -84% | -$80.5K |
|
2683
ORIX
IX
$29.8B
| $15.4K | ﹤0.01% |
825
-3,265
| -80% | -$60.9K |
|
2684
Apellis Pharmaceuticals
APLS
$3.29B
| $15.3K | ﹤0.01% |
256
-35,215
| -99% | -$2.11M |
|
2685
Atea Pharmaceuticals
AVIR
$250M
| $15K | ﹤0.01% |
4,910
+241
| +5% | +$735 |
|
2686
Mission Produce
AVO
$829M
| $14.8K | ﹤0.01% |
+1,470
| New | +$14.8K |
|
2687
Cambium Networks
CMBM
$19.8M
| $14.6K | ﹤0.01% |
2,440
+559
| +30% | +$3.35K |
|
|
MACK
2688
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $14.3K | ﹤0.01% |
1,066
+202
| +23% | +$2.71K |
|
2689
Liberty Broadband Class A
LBRDA
$8.61B
| $14.1K | ﹤0.01% |
175
-13
| -7% | -$1.05K |
|
2690
iShares MSCI USA Value Factor ETF
VLUE
$7.21B
| $14.1K | ﹤0.01% |
139
| – | – |
|
2691
Riley Exploration Permian
REPX
$619M
| $14.1K | ﹤0.01% |
+516
| New | +$14.1K |
|
2692
SGHC Ltd
SGHC
$6.57B
| $13.9K | ﹤0.01% |
+4,383
| New | +$13.9K |
|
2693
Prothena Corp
PRTA
$447M
| $13.9K | ﹤0.01% |
+382
| New | +$13.9K |
|
|
GPMT
2694
Granite Point Mortgage Trust
GPMT
$142M
| $13.7K | ﹤0.01% |
2,298
+1,044
| +83% | +$6.2K |
|
2695
Bakkt Holdings
BKKT
$135M
| $13.6K | ﹤0.01% |
+244
| New | +$13.6K |
|
2696
Cidara Therapeutics
CDTX
$1.61B
| $13.6K | ﹤0.01% |
855
| – | – |
|
2697
Jack in the Box
JACK
$345M
| $13.6K | ﹤0.01% |
166
+29
| +21% | +$2.37K |
|
2698
Globalstar
GSAT
$3.94B
| $13.5K | ﹤0.01% |
466
| – | – |
|
2699
Agios Pharmaceuticals
AGIO
$2.07B
| $13.5K | ﹤0.01% |
604
-1,639
| -73% | -$36.5K |
|
2700
iShares MSCI Australia ETF
EWA
$1.54B
| $13.3K | ﹤0.01% |
547
-5
| -0.9% | -$122 |
|